Sumant Ramachandra, Director at Lyell Immunopharma, Inc. (LYEL), bought 400,000 shares at $0.58 ($232K) on 2025-03-21, disclosed to the SEC on 2025-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.58 | 200,000 | $116K | 50.0% |
| 2 | $0.58 | 200,000 | $116K | 50.0% |
| Total | $0.58 avg | 400,000 | $232K | 100% |
| Filing → |